2. Academic Validation
  3. Opioid δ₁ receptor antagonist 7-benzylidenenaltrexone as an effective resistance reverser for chloroquine-resistant Plasmodium chabaudi

Opioid δ₁ receptor antagonist 7-benzylidenenaltrexone as an effective resistance reverser for chloroquine-resistant Plasmodium chabaudi

  • Bioorg Med Chem Lett. 2011 Aug 15;21(16):4710-2. doi: 10.1016/j.bmcl.2011.06.085.
Yoshinori Miyata 1,  Hideaki Fujii,  Yumiko Osa,  Seiki Kobayashi,  Tsutomu Takeuchi,  Hiroshi Nagase
Affiliations

Affiliation

  • 1 School of Pharmacy, Kitasato University, 5-9-1, Shirokane, Minato-ku, Tokyo 108-8641, Japan.
PMID: 21764311 DOI: 10.1016/j.bmcl.2011.06.085
Abstract

We evaluated antimalarial and/or chloroquine-resistance reversing effects of five Opioid Receptor antagonists. Although none of the evaluated compounds showed antimalarial effects, some of them, especially the δ(1) receptor antagonist, 7-benzylidenenaltrexone (BNTX) exhibited potent chloroquine-resistance reversing effects in Plasmodium chabaudi.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z